Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (111-120 of 227) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|July 18, 2022
The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosisEnrico Girardi, Yanink Caro-Vega, Alessandro Cozzi-Lepri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 6, 2025
Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohortMariacristina Poliseno, Sergio Lo Caputo, Alessandro Tavelli, et al.
AIDS (London, England)|June 20, 2015
HIV resistance testing and detected drug resistance in EuropeAnna Schultze, Andrew N Phillips, Roger Paredes, et al.
Journal of the International AIDS Society|November 15, 2014
Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppressionJosep M Llibre, Alessandro Cozzi-Lepri, Jorge Antonio Valencia La Rosa, et al.
HIV Medicine|December 2, 2024
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Eugenia Quiros-Roldan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2023
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Roberto Rossotti, et al.
AIDS (London, England)|March 2, 2002
Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?Antonia L Moore, Mike Youle, Marc Lipman, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Antiviral Therapy|September 13, 2006
Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparisonAndrea De Luca, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
The Journal of Infectious Diseases|August 2, 2014
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patientsMiriam Lichtner, Paola Cicconi, Serena Vita, et al.
Pageof 23

Showing results (111-120 of 227) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|July 18, 2022
The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosisEnrico Girardi, Yanink Caro-Vega, Alessandro Cozzi-Lepri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 6, 2025
Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohortMariacristina Poliseno, Sergio Lo Caputo, Alessandro Tavelli, et al.
AIDS (London, England)|June 20, 2015
HIV resistance testing and detected drug resistance in EuropeAnna Schultze, Andrew N Phillips, Roger Paredes, et al.
Journal of the International AIDS Society|November 15, 2014
Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppressionJosep M Llibre, Alessandro Cozzi-Lepri, Jorge Antonio Valencia La Rosa, et al.
HIV Medicine|December 2, 2024
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Eugenia Quiros-Roldan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2023
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Roberto Rossotti, et al.
AIDS (London, England)|March 2, 2002
Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?Antonia L Moore, Mike Youle, Marc Lipman, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Antiviral Therapy|September 13, 2006
Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparisonAndrea De Luca, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
The Journal of Infectious Diseases|August 2, 2014
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patientsMiriam Lichtner, Paola Cicconi, Serena Vita, et al.
Pageof 23